Balance Sheet Sekisui House, Ltd.

Equities

1928

JP3420600003

Homebuilding

Market Closed - Japan Exchange Other stock markets 06:30:00 12/12/2025 GMT			5-day change	1st Jan Change
3,460.00 ^JPY	+1.26%		+3.81%	-8.51%

12-04	Sekisui House, Ltd. Provides Consolidated Earning Guidance for the Fiscal Year Ending January 31, 2026	CI
12-04	Sekisui House, Ltd. Announces Dividend for the Second Quarter-End of Fiscal Year Ending January 31, 2026	CI

b29b55ffeb4dcd3eee884.FEnKDd6mqvAj8JHWBoRH7JoAQ9769TAJEqLNC54pmp8.QjOcNLqe2JURo_qbbOYinfRHMqm0nV9PfM-ZfK188_VeMZtipMTmvlS9xA

Published financial data: SEKISUI HOUSE, LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: January	2021	2022	2023	2024	2025
Revenues	2,447B	2,590B	2,929B	3,107B	4,059B
Total Revenues	2,447B	2,590B	2,929B	3,107B	4,059B
Cost of Goods Sold, Total	1,973B	2,061B	2,345B	2,483B	3,273B
Gross Profit	474B	529B	584B	624B	786B
Selling General & Admin Expenses, Total	287B	299B	323B	353B	454B
Provision for Bad Debts	106M	98M	110M	-553M	857M
Other Operating Expenses, Total	287B	299B	323B	352B	455B
Operating Income	187B	230B	261B	272B	331B
Interest Expense, Total	-2.77B	-3.84B	-5.32B	-12.37B	-33.63B
Interest And Investment Income	4.94B	4.51B	4.38B	5.14B	11.45B
Net Interest Expenses	2.17B	672M	-937M	-7.23B	-22.18B
Income (Loss) On Equity Invest.	619M	-1.24B	-2.09B	1.9B	-3.08B
Currency Exchange Gains (Loss)	-3.58B	1.13B	-723M	4.29B	3.58B
Other Non Operating Income (Expenses)	-1.04B	-636M	-472M	-1.67B	-8.05B
EBT, Excl. Unusual Items	185B	230B	257B	269B	302B
Gain (Loss) On Sale Of Investments	3.09B	6.43B	17.09B	25.98B	23.92B
Gain (Loss) On Sale Of Assets	-1.32B	-1.63B	-1.76B	-5.42B	-1.58B
Asset Writedown	-356M	-539M	-2.9B	-484M	-147M
Other Unusual Items	-617M	-20M	-1.99B	0	-18.23B
EBT, Incl. Unusual Items	185B	234B	268B	289B	306B
Income Tax Expense	56.07B	70.32B	76.38B	81.43B	84.33B
Earnings From Continuing Operations	129B	164B	191B	208B	221B
Net Income to Company	129B	164B	191B	208B	221B
Minority Interest	-5.88B	-10.11B	-6.81B	-5.2B	-3.55B
Net Income - (IS)	124B	154B	185B	202B	218B
Net Income to Common Incl Extra Items	124B	154B	185B	202B	218B
Net Income to Common Excl. Extra Items	124B	154B	185B	202B	218B
Per Share Items
Net EPS - Basic	181.18	227.37	276.58	309.29	335.95
Basic EPS - Continuing Operations	181.18	227.37	276.58	309.29	335.95
Basic Weighted Average Shares Outstanding	682M	677M	667M	654M	648M
Net EPS - Diluted	181.02	227.25	276.46	309.19	335.84
Diluted EPS - Continuing Operations	181.02	227.25	276.46	309.19	335.84
Diluted Weighted Average Shares Outstanding	682M	677M	667M	654M	648M
Normalized Basic EPS	160.66	197.52	230.81	248.95	285.42
Normalized Diluted EPS	160.52	197.41	230.71	248.87	285.34
Dividend Per Share	79	90	110	123	135
Payout Ratio	47.54	36.13	35.99	37.99	38.11
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	208B	254B	288B	299B	367B
EBITA	187B	230B	261B	272B	331B
EBIT	187B	230B	261B	272B	331B
Effective Tax Rate - (Ratio)	30.23	30.01	28.53	28.18	27.6
Normalized Net Income	110B	134B	154B	163B	185B
Non-Cash Pension Expense	4.2B	1.63B	-1.04B	-2.99B	-11.97B
Supplemental Operating Expense Items
Advertising Expense	54.47B	55.93B	54.68B	58.86B	87.04B
Selling and Marketing Expenses	54.47B	55.93B	54.68B	58.86B	87.04B
Research And Development Expense From Footnotes	9.66B	9.48B	9.56B	9.05B	10.58B

Fiscal Period: January	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	600B	515B	333B	293B	391B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	600B	515B	333B	293B	391B
Accounts Receivable, Total	143B	131B	156B	175B	210B
Total Receivables	143B	131B	156B	175B	210B
Inventory	948B	1,204B	1,465B	1,894B	2,866B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	89.5B	102B	140B	135B	246B
Total Current Assets	1,781B	1,953B	2,094B	2,497B	3,712B
Net Property Plant And Equipment	535B	541B	555B	496B	534B
Long-term Investments	246B	260B	284B	295B	316B
Goodwill	1.58B	250M	31.41B	17.81B	134B
Other Intangibles, Total	18.15B	17.74B	19.71B	22.58B	87.66B
Loans Receivable Long-Term	18.95B	5.79B	5.64B	3.97B	13.66B
Deferred Tax Assets Long-Term	24.6B	24.09B	18.22B	20.24B	10.64B
Other Long-Term Assets, Total	1M	2M	2M	2M	1M
Total Assets	2,626B	2,801B	3,008B	3,353B	4,809B
Liabilities
Accounts Payable, Total	203B	208B	227B	237B	274B
Accrued Expenses, Total	27.36B	32.66B	37.52B	39.25B	46.38B
Short-term Borrowings	166B	219B	306B	440B	518B
Current Portion of Long-Term Debt	86.52B	16.24B	102B	21.63B	253B
Current Income Taxes Payable	29.7B	43.02B	34.64B	39.78B	44.65B
Unearned Revenue Current, Total	209B	208B	192B	210B	221B
Other Current Liabilities	115B	141B	146B	150B	199B
Total Current Liabilities	836B	868B	1,045B	1,138B	1,556B
Long-Term Debt	303B	307B	177B	289B	1,076B
Pension & Other Post Retirement Benefits	43.87B	31.6B	29.98B	31.42B	32.49B
Deferred Tax Liability Non Current	364M	464M	933M	6.11B	13.44B
Other Non Current Liabilities	74.32B	73.71B	87.07B	94.08B	112B
Total Liabilities	1,257B	1,280B	1,340B	1,559B	2,790B
Common Stock, Total	203B	203B	203B	203B	203B
Additional Paid In Capital	259B	259B	260B	260B	260B
Retained Earnings	840B	940B	1,056B	1,132B	1,267B
Treasury Stock	-6.88B	-20.98B	-50.66B	-40.98B	-40.96B
Comprehensive Income and Other	32.36B	93.38B	165B	200B	273B
Total Common Equity	1,327B	1,474B	1,633B	1,755B	1,962B
Minority Interest	41.84B	46.83B	34.58B	39.37B	56.31B
Total Equity	1,369B	1,521B	1,668B	1,794B	2,019B
Total Liabilities And Equity	2,626B	2,801B	3,008B	3,353B	4,809B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	681M	675M	662M	648M	648M
ECS Total Common Shares Outstanding	681M	675M	662M	648M	648M
Book Value / Share	1.95K	2.18K	2.47K	2.71K	3.03K
Tangible Book Value	1,307B	1,456B	1,582B	1,714B	1,740B
Tangible Book Value Per Share	1.92K	2.16K	2.39K	2.65K	2.69K
Total Debt	555B	542B	585B	751B	1,847B
Net Debt	-45.08B	26.73B	252B	458B	1,457B
Debt Equivalent of Unfunded Proj. Benefit Obligation	41.63B	23.53B	-3.22B	-4.72B	-15.12B
Minority Interest, Total (Incl. Fin. Div)	41.84B	46.83B	34.58B	39.37B	56.31B
Inventories - Raw Materials, Total	89.53B	154B	182B	238B	401B
Inventories - Work In Process, Total	20.54B	23.58B	24.78B	24.84B	21.62B
Inventories - Finished Goods, Total	838B	1,027B	1,258B	1,631B	2,443B
Full Time Employees	28.36K	28.82K	29.05K	29.93K	32.26K
Accumulated Allowance for Doubtful Accounts (Supple)	1.07B	1.18B	1.14B	1.03B	1.01B
Order Backlog	1,363B	1,513B	1,448B	1,552B	1,755B

Fiscal Period: January	2021	2022	2023	2024	2025
Net Income	185B	234B	268B	289B	306B
Depreciation & Amortization - CF	21.73B	24.07B	26.71B	27.74B	35.24B
Depreciation & Amortization, Total	21.73B	24.07B	26.71B	27.74B	35.24B
(Gain) Loss From Sale Of Asset	356M	539M	2.9B	484M	147M
(Gain) Loss on Sale of Investments - (CF)	-3.09B	-3.34B	-274M	-16.2B	-20.47B
(Income) Loss On Equity Investments - (CF)	-619M	1.24B	2.09B	-1.9B	3.08B
Other Operating Activities, Total	-59.05B	-61.79B	-88.92B	-69.37B	-83.92B
Change In Accounts Receivable	-10.25B	13.46B	-24.16B	-19.11B	-32.74B
Change In Inventories	71.85B	-85.52B	-38.49B	-218B	-101B
Change In Accounts Payable	-14.67B	17.64B	8.28B	8.3B	-11.56B
Change in Other Net Operating Assets	225M	-22.61B	-30.37B	14.78B	-31.4B
Cash from Operations	192B	118B	125B	15.68B	62.88B
Capital Expenditure	-87.49B	-82.95B	-92.16B	-76.94B	-76.69B
Sale of Property, Plant, and Equipment	1.18B	727M	2.84B	437M	798M
Cash Acquisitions	-	-35.7B	-69.6B	-14.54B	-557B
Divestitures	-	87M	-	2.88B	-854M
Investment in Marketable and Equity Securities, Total	-5.5B	-7.82B	-2.15B	19.5B	25.81B
Net (Increase) Decrease in Loans Originated / Sold - Investing	874M	9.48B	261M	2.59B	-74.66B
Other Investing Activities, Total	-4.57B	2.47B	-4.6B	-3.05B	-15.19B
Cash from Investing	-95.5B	-114B	-165B	-69.12B	-698B
Short Term Debt Issued, Total	8.97B	33.22B	37.36B	156B	40B
Long-Term Debt Issued, Total	28.67B	26.75B	66.29B	85.54B	817B
Total Debt Issued	37.63B	59.97B	104B	241B	857B
Short Term Debt Repaid, Total	-	-	-	-	-12.78B
Long-Term Debt Repaid, Total	-47.35B	-94.17B	-142B	-116B	-38.89B
Total Debt Repaid	-47.35B	-94.17B	-142B	-116B	-51.67B
Repurchase of Common Stock	-5.01B	-15.02B	-30.01B	-40.02B	-18M
Common Dividends Paid	-58.73B	-55.61B	-66.4B	-76.86B	-82.97B
Common & Preferred Stock Dividends Paid	-58.73B	-55.61B	-66.4B	-76.86B	-82.97B
Other Financing Activities, Total	-4.16B	-6.88B	-21.25B	-2.44B	-1.48B
Cash from Financing	-77.61B	-112B	-156B	6.48B	721B
Foreign Exchange Rate Adjustments	-1.92B	20.12B	13.3B	7.11B	11.24B
Miscellaneous Cash Flow Adjustments	-1M	2.19B	1M	-	-
Net Change in Cash	16.94B	-85.06B	-182B	-39.85B	97.4B
Supplemental Items
Cash Interest Paid	3.57B	4.53B	6.81B	16.44B	32.76B
Cash Income Tax Paid (Refund)	58.5B	64.74B	94.49B	65.93B	84.02B
Levered Free Cash Flow	61.56B	-125B	-224B	-291B	-864B
Unlevered Free Cash Flow	63.29B	-123B	-221B	-283B	-843B
Change In Net Working Capital	-12.48B	208B	319B	404B	1,009B
Net Debt Issued / Repaid	-9.72B	-34.2B	-38.12B	126B	805B

Fiscal Period: January	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.43	5.3	5.63	5.34	5.08
Return on Total Capital	6.12	7.22	7.57	7.08	6.46
Return On Equity %	9.67	11.35	12	11.99	11.61
Return on Common Equity	9.53	10.99	11.88	11.94	11.71
Margin Analysis
Gross Profit Margin %	19.35	20.42	19.95	20.07	19.37
SG&A Margin	11.72	11.53	11.02	11.35	11.18
EBITDA Margin %	8.51	9.82	9.84	9.63	9.03
EBITA Margin %	7.62	8.89	8.93	8.74	8.16
EBIT Margin %	7.62	8.89	8.93	8.74	8.16
Income From Continuing Operations Margin %	5.29	6.33	6.53	6.68	5.45
Net Income Margin %	5.05	5.94	6.3	6.51	5.36
Net Avail. For Common Margin %	5.05	5.94	6.3	6.51	5.36
Normalized Net Income Margin	4.48	5.16	5.26	5.24	4.56
Levered Free Cash Flow Margin	2.52	-4.84	-7.64	-9.37	-21.3
Unlevered Free Cash Flow Margin	2.59	-4.74	-7.53	-9.12	-20.78
Asset Turnover
Asset Turnover	0.93	0.95	1.01	0.98	0.99
Fixed Assets Turnover	4.68	4.81	5.35	5.91	7.88
Receivables Turnover (Average Receivables)	17.73	18.87	20.39	18.75	21.05
Inventory Turnover (Average Inventory)	2.02	1.91	1.76	1.48	1.38
Short Term Liquidity
Current Ratio	2.13	2.25	2	2.19	2.39
Quick Ratio	0.89	0.74	0.47	0.41	0.39
Operating Cash Flow to Current Liabilities	0.23	0.14	0.12	0.01	0.04
Days Sales Outstanding (Average Receivables)	20.64	19.34	17.9	19.47	17.38
Days Outstanding Inventory (Average Inventory)	181.1	190.61	207.78	246.8	266.14
Average Days Payable Outstanding	40.34	32.32	30.44	29.08	22.06
Cash Conversion Cycle (Average Days)	161.41	177.63	195.24	237.18	261.46
Long Term Solvency
Total Debt/Equity	40.56	35.64	35.05	41.85	91.5
Total Debt / Total Capital	28.86	26.27	25.96	29.5	47.78
LT Debt/Equity	22.11	20.16	10.64	16.11	53.33
Long-Term Debt / Total Capital	15.73	14.86	7.88	11.36	27.85
Total Liabilities / Total Assets	47.87	45.7	44.55	46.49	58.02
EBIT / Interest Expense	67.36	60	49.18	21.95	9.85
EBITDA / Interest Expense	75.21	66.27	54.2	24.2	10.9
(EBITDA - Capex) / Interest Expense	43.61	44.65	36.87	17.98	8.62
Total Debt / EBITDA	2.67	2.13	2.03	2.51	5.04
Net Debt / EBITDA	-0.22	0.11	0.87	1.53	3.97
Total Debt / (EBITDA - Capex)	4.6	3.16	2.98	3.38	6.37
Net Debt / (EBITDA - Capex)	-0.37	0.16	1.28	2.06	5.02
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.31	5.83	13.1	6.09	30.62
Gross Profit, 1 Yr. Growth %	-0.95	11.69	10.48	6.75	26.01
EBITDA, 1 Yr. Growth %	-8.17	22.08	13.36	3.86	22.47
EBITA, 1 Yr. Growth %	-9.13	23.4	13.61	3.86	22.01
EBIT, 1 Yr. Growth %	-9.13	23.4	13.61	3.86	22.01
Earnings From Cont. Operations, 1 Yr. Growth %	-12.86	26.73	16.65	8.47	6.62
Net Income, 1 Yr. Growth %	-12.54	24.58	19.89	9.65	7.6
Normalized Net Income, 1 Yr. Growth %	-13.34	22.04	15.18	5.75	13.58
Diluted EPS Before Extra, 1 Yr. Growth %	-11.94	25.54	21.65	11.84	8.62
Accounts Receivable, 1 Yr. Growth %	7.82	-8.3	18.81	12.47	19.76
Inventory, 1 Yr. Growth %	-5.72	27.09	21.61	29.28	51.32
Net Property, Plant and Equip., 1 Yr. Growth %	4.86	0.99	2.56	-10.51	7.65
Total Assets, 1 Yr. Growth %	-0.34	6.68	7.37	11.48	43.43
Tangible Book Value, 1 Yr. Growth %	4.74	11.38	8.63	8.37	1.52
Common Equity, 1 Yr. Growth %	4.76	11.08	10.78	7.45	11.83
Cash From Operations, 1 Yr. Growth %	-47.23	-38.52	6.29	-87.5	300.98
Capital Expenditures, 1 Yr. Growth %	31.32	-5.19	11.1	-16.52	-0.32
Levered Free Cash Flow, 1 Yr. Growth %	-76.65	-303.42	78.76	30.06	196.93
Unlevered Free Cash Flow, 1 Yr. Growth %	-76.27	-294.06	79.55	28.51	197.61
Dividend Per Share, 1 Yr. Growth %	-2.47	13.92	22.22	11.82	9.76
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.43	3.55	9.41	9.54	17.72
Gross Profit, 2 Yr. CAGR %	3.2	5.18	11.08	8.6	15.98
EBITDA, 2 Yr. CAGR %	-0.74	5.88	17.64	8.51	12.78
EBITA, 2 Yr. CAGR %	-0.72	5.89	18.4	8.63	12.57
EBIT, 2 Yr. CAGR %	-0.72	5.89	18.4	8.63	12.57
Earnings From Cont. Operations, 2 Yr. CAGR %	-0.07	5.08	21.59	12.48	7.54
Net Income, 2 Yr. CAGR %	-1.98	4.38	22.21	14.66	8.62
Normalized Net Income, 2 Yr. CAGR %	-4.83	2.84	18.56	10.36	9.6
Diluted EPS Before Extra, 2 Yr. CAGR %	-1.42	5.14	23.58	16.64	10.22
Accounts Receivable, 2 Yr. CAGR %	86.73	-0.57	4.38	15.6	16.06
Inventory, 2 Yr. CAGR %	-7.19	9.46	24.32	25.39	39.87
Net Property, Plant and Equip., 2 Yr. CAGR %	0.47	2.91	1.77	-4.2	-1.85
Total Assets, 2 Yr. CAGR %	4.32	3.11	7.02	9.4	26.45
Tangible Book Value, 2 Yr. CAGR %	6.02	8.01	10	8.5	4.89
Common Equity, 2 Yr. CAGR %	5.89	7.87	10.93	9.1	9.62
Cash From Operations, 2 Yr. CAGR %	23.88	-43.04	-19.16	-63.55	-29.2
Capital Expenditures, 2 Yr. CAGR %	27.43	11.58	2.64	-3.69	-8.78
Levered Free Cash Flow, 2 Yr. CAGR %	4.06	-31.08	90.69	52.48	96.51
Unlevered Free Cash Flow, 2 Yr. CAGR %	2.87	-32.14	86.66	51.9	95.57
Dividend Per Share, 2 Yr. CAGR %	0	5.41	18	16.9	10.78
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.26	6.23	6.64	8.29	16.16
Gross Profit, 3 Yr. CAGR %	2.09	5.96	6.92	9.62	14.12
EBITDA, 3 Yr. CAGR %	-1.44	6.35	8.32	12.86	12.98
EBITA, 3 Yr. CAGR %	-1.56	6.75	8.41	13.34	12.92
EBIT, 3 Yr. CAGR %	-1.56	6.75	8.41	13.34	12.92
Earnings From Cont. Operations, 3 Yr. CAGR %	-2.4	8.16	8.81	17.04	10.49
Net Income, 3 Yr. CAGR %	-2.48	6.18	9.31	17.87	12.25
Normalized Net Income, 3 Yr. CAGR %	-3.35	3.39	6.8	14.13	11.43
Diluted EPS Before Extra, 3 Yr. CAGR %	-2.08	6.85	10.38	19.54	13.9
Accounts Receivable, 3 Yr. CAGR %	47.51	47.32	5.51	7.01	16.97
Inventory, 3 Yr. CAGR %	-4.7	3.06	13.37	25.95	33.5
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.06	0.64	2.79	-2.5	-0.4
Total Assets, 3 Yr. CAGR %	2.77	5.1	4.51	8.49	19.74
Tangible Book Value, 3 Yr. CAGR %	3.66	7.78	8.22	9.45	6.12
Common Equity, 3 Yr. CAGR %	3.53	7.59	8.83	9.76	10
Cash From Operations, 3 Yr. CAGR %	5.1	-1.92	-29.87	-56.61	-18.93
Capital Expenditures, 3 Yr. CAGR %	11.63	15.47	11.42	-4.19	-2.58
Levered Free Cash Flow, 3 Yr. CAGR %	70.55	30.11	-5.31	67.85	90.41
Unlevered Free Cash Flow, 3 Yr. CAGR %	84.51	27.11	-6.14	64.82	90.07
Dividend Per Share, 3 Yr. CAGR %	0.86	4.44	10.74	15.9	14.47
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.65	5.02	6.29	7.54	10.94
Gross Profit, 5 Yr. CAGR %	4.84	4.8	5.59	7.01	10.46
EBITDA, 5 Yr. CAGR %	3.65	4.17	5.79	7.21	10.08
EBITA, 5 Yr. CAGR %	4.5	4.56	5.98	7.49	10.05
EBIT, 5 Yr. CAGR %	4.5	4.56	5.98	7.49	10.05
Earnings From Cont. Operations, 5 Yr. CAGR %	8.47	5.27	6.57	9.87	8.3
Net Income, 5 Yr. CAGR %	7.94	4.78	6.73	9.49	9.04
Normalized Net Income, 5 Yr. CAGR %	2.15	3.18	4.88	6.13	7.91
Diluted EPS Before Extra, 5 Yr. CAGR %	8.68	5.34	7.47	10.66	10.32
Accounts Receivable, 5 Yr. CAGR %	23.9	22.36	28.45	33.7	9.61
Inventory, 5 Yr. CAGR %	0.71	3.84	5.99	11.47	23.31
Net Property, Plant and Equip., 5 Yr. CAGR %	0.08	-0.83	0.06	-1.32	0.91
Total Assets, 5 Yr. CAGR %	5.28	5.1	4.45	6.8	12.79
Tangible Book Value, 5 Yr. CAGR %	4.61	5.95	6.15	8.07	6.88
Common Equity, 5 Yr. CAGR %	4.63	5.95	6.43	8.19	9.15
Cash From Operations, 5 Yr. CAGR %	33.14	0.38	-5.37	-33.99	-29.6
Capital Expenditures, 5 Yr. CAGR %	2.37	-2.59	7.94	7.39	2.86
Levered Free Cash Flow, 5 Yr. CAGR %	1.55	108.29	78.34	38.63	26.81
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.35	92.49	85.37	36.5	25.89
Dividend Per Share, 5 Yr. CAGR %	7.91	7.06	7.39	9.26	10.76